BIOCRYST PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of BCRX for the last quarter is 1.59 B MXN, and it's 4.92% higher compared to the previous quarter. The net income of Q4 23 is -1.05 B MXN.